Your browser doesn't support javascript.
loading
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.
Hallacli, Erinc; Kayatekin, Can; Nazeen, Sumaiya; Wang, Xiou H; Sheinkopf, Zoe; Sathyakumar, Shubhangi; Sarkar, Souvarish; Jiang, Xin; Dong, Xianjun; Di Maio, Roberto; Wang, Wen; Keeney, Matthew T; Felsky, Daniel; Sandoe, Jackson; Vahdatshoar, Aazam; Udeshi, Namrata D; Mani, D R; Carr, Steven A; Lindquist, Susan; De Jager, Philip L; Bartel, David P; Myers, Chad L; Greenamyre, J Timothy; Feany, Mel B; Sunyaev, Shamil R; Chung, Chee Yeun; Khurana, Vikram.
Afiliação
  • Hallacli E; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Whitehead Institute for Biomedical Resea
  • Kayatekin C; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
  • Nazeen S; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Biomedical Informatics, Ha
  • Wang XH; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Sheinkopf Z; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Sathyakumar S; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Sarkar S; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Jiang X; Yumanity Therapeutics, Boston, MA 02135, USA.
  • Dong X; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Genomics and Bioinformatics Hub, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Researc
  • Di Maio R; Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, Pittsburgh, PA 15213, USA.
  • Wang W; Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Keeney MT; Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, Pittsburgh, PA 15213, USA.
  • Felsky D; Krembil Centre for Neuroinformatics and Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada; Division of Biostatistics, Dalla Lana School of Pu
  • Sandoe J; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
  • Vahdatshoar A; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Udeshi ND; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Mani DR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Lindquist S; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Cambridge, MA 02142, USA; Department of Biology, MIT, Cambridge, MA 02139, USA.
  • De Jager PL; Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Bartel DP; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Cambridge, MA 02142, USA; Department of Biology, MIT, Cambridge, MA 02139, USA.
  • Myers CL; Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
  • Greenamyre JT; Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, Pittsburgh, PA 15213, USA.
  • Feany MB; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Sunyaev SR; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
  • Chung CY; Yumanity Therapeutics, Boston, MA 02135, USA.
  • Khurana V; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Aligning Science Across Parkinson's (ASA
Cell ; 185(12): 2035-2056.e33, 2022 06 09.
Article em En | MEDLINE | ID: mdl-35688132
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article